Skip to main content
OpenTrials
Completed

NCT Number: NCT00939224

Study of Non-Invasive Regional Oxygen Saturations in Pediatric Patients Undergoing Cardiac Catheterization

The purpose of this study is to validate the Nonin Near-infrared spectroscopy (NIRS) device to measure regional oxygen saturation in a cohort of children with cardiovascular disease undergoing cardiac catheterization.

Completed

Looking for future studies?

Notify Me

Key information

Age range

Up to 12 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Stanford University School of Medicine, Stanford, California, United States

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • The subject is male or female;
  • The subject is of any racial or ethnic group;
  • The subject is between 0 days and 12 years of age;
  • Is less than 40 kg;
  • The subject is scheduled for a cardiac catheterization for treatment or diagnosis of a cardiovascular disease;
  • The scheduled cardiac catheterization includes catheter placements in the central venous circulation and central arterial circulation, or catheter placement in the central venous circulation with a pre-existing arterial catheter;
  • The subject is American Society Anesthesiologist (ASA) status 1 through 4; and
  • The subject's legally authorized representative has given written informed consent to participate in the study and, when appropriate, the subject has given assent to participate.

Exclusion criteria

  • Is greater than twelve (12) years of age;
  • Has pre-existing allergies to adhesive tapes or adhesives on neonatal ECG pads;
  • Has pre-existing skin condition at the site where the Nonin cerebral oximeter sensor will be placed (e.g., eczema, dermatitis);
  • Has craniofacial disease preventing application of the sensor to the forehead;
  • Has sickle cell anemia or other hemoglobinopathy;
  • Has disease of the cerebrovasculature including the jugular or carotid vessels;
  • Was previously on ECMO involving the carotid or jugular vessels that could have resulted in disease or ligation;
  • Is not able to be in a supine position with cardiac catheterization laboratory table angle zero degrees with a neutral neck position at zero degrees rotation;
  • Has acute neurological injury (seizure, stroke, encephalopathy, meningoencephalitis currently or within the past 10 days), or a structural brain lesion (eg, arteriovenous malformation, cyst) in the optical field beneath the sensor;
  • Has an emergency, life-threatening condition (American Society of Anesthesiologists Physical status 5 or 6) impacting the ability to obtain informed consent;
  • Or has another condition, which in the opinion of the principal investigator would not be suitable for participation in the study.

Treatment and study plan

Model 7600 Regional Oximeter System

Device

Non-invasive regional oxygen saturation measurements

Primary outcomes

  1. The success of the validation and calibration will be assessed through the Arms statistic.

    Time frame: Single visit

Secondary outcomes

  1. Tissue (somatic) sensor readings will be described using the descriptive statistics.

    Time frame: Single Visit

Sponsors and collaborators

Lead sponsor

Nonin Medical, Inc

Industry

Registry information

Official study title

Calibration and Validation of the a Non-Invasive Regional Oxygen Saturation Device in Neonates, Infants and Children Undergoing Cardiac Catheterization

Important dates

Study start
2009
Primary completion
2011
Study completion
2011
First posted
Jul 14, 2009
Registry last updated
Aug 25, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.